Article
Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals.
Viruses - 18 Dec 2015
Ahmed Asma, Felmlee Daniel J
Abstract excerpt
There has been a remarkable transformation in the treatment of chronic hepatitis C in recent years with the development of direct acting antiviral agents targeting virus encoded proteins important for viral replication including NS3/4A, NS5A and NS5B. These agents have shown high sustained viral response (SVR) rates of more than 90% in phase 2 and phase 3 clinical trials; however, this is slightly lower in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
